» Articles » PMID: 34452258

When Cyclodextrins Met Data Science: Unveiling Their Pharmaceutical Applications Through Network Science and Text-Mining

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2021 Aug 28
PMID 34452258
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

We present a data-driven approach to unveil the pharmaceutical technologies of cyclodextrins (CDs) by analyzing a dataset of CD pharmaceutical patents. First, we implemented network science techniques to represent CD patents as a single structure and provide a framework for unsupervised detection of keywords in the patent dataset. Guided by those keywords, we further mined the dataset to examine the patenting trends according to CD-based dosage forms. CD patents formed complex networks, evidencing the supremacy of CDs for solubility enhancement and how this has triggered cutting-edge applications based on or beyond the solubility improvement. The networks exposed the significance of CDs to formulate aqueous solutions, tablets, and powders. Additionally, they highlighted the role of CDs in formulations of anti-inflammatory drugs, cancer therapies, and antiviral strategies. Text-mining showed that the trends in CDs for aqueous solutions, tablets, and powders are going upward. Gels seem to be promising, while patches and fibers are emerging. Cyclodextrins' potential in suspensions and emulsions is yet to be recognized and can become an opportunity area. This is the first unsupervised/supervised data-mining approach aimed at depicting a landscape of CDs to identify trending and emerging technologies and uncover opportunity areas in CD pharmaceutical research.

Citing Articles

A Review of Machine Learning and QSAR/QSPR Predictions for Complexes of Organic Molecules with Cyclodextrins.

Boczar D, Michalska K Molecules. 2024; 29(13).

PMID: 38999108 PMC: 11243237. DOI: 10.3390/molecules29133159.


Machine learning approaches for biomolecular, biophysical, and biomaterials research.

Rickert C, Lieleg O Biophys Rev (Melville). 2024; 3(2):021306.

PMID: 38505413 PMC: 10914139. DOI: 10.1063/5.0082179.


Change in the Kinetic Regime of Aggregation of Yeast Alcohol Dehydrogenase in the Presence of 2-Hydroxypropyl-β-cyclodextrin.

Borzova V, Chernikov A, Mikhaylova V, Kurganov B Int J Mol Sci. 2023; 24(22).

PMID: 38003330 PMC: 10671268. DOI: 10.3390/ijms242216140.


The Role of Cyclodextrin in the Construction of Nanoplatforms: From Structure, Function and Application Perspectives.

Xing C, Zheng X, Deng T, Zeng L, Liu X, Chi X Pharmaceutics. 2023; 15(5).

PMID: 37242778 PMC: 10221680. DOI: 10.3390/pharmaceutics15051536.


Data-Driven Technology Roadmaps to Identify Potential Technology Opportunities for Hyperuricemia Drugs.

Feng L, Zhao W, Wang J, Lin K, Guo Y, Zhang L Pharmaceuticals (Basel). 2022; 15(11).

PMID: 36355529 PMC: 9694917. DOI: 10.3390/ph15111357.


References
1.
Jansook P, Kulsirachote P, Asasutjarit R, Loftsson T . Development of celecoxib eye drop solution and microsuspension: A comparative investigation of binary and ternary cyclodextrin complexes. Carbohydr Polym. 2019; 225:115209. DOI: 10.1016/j.carbpol.2019.115209. View

2.
Braga S . Cyclodextrins: Emerging Medicines of the New Millennium. Biomolecules. 2019; 9(12). PMC: 6995511. DOI: 10.3390/biom9120801. View

3.
Cal K, Centkowska K . Use of cyclodextrins in topical formulations: practical aspects. Eur J Pharm Biopharm. 2007; 68(3):467-78. DOI: 10.1016/j.ejpb.2007.08.002. View

4.
de Oliveira-Filho R, E Silva A, de Azevedo Moreira R, Nogueira N . Biological Activities and Pharmacological Applications of Cyclodextrins Complexed with Essential Oils and Their Volatile Components: A Systematic Review. Curr Pharm Des. 2018; 24(33):3951-3963. DOI: 10.2174/1381612824666181120093634. View

5.
Liu S, Ho P . Intranasal administration of brain-targeted HP-β-CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia. J Pharm Pharmacol. 2017; 69(11):1495-1501. DOI: 10.1111/jphp.12797. View